http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0514792-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff6b1dd65776c7e20971be77f60a441d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
filingDate 2005-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_378fd4e6737f0ae60dc7fcb36ffce7b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57d11a5775eb8604b2fc1f263f0b9a30
publicationDate 2008-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0514792-A
titleOfInvention compound, use of a compound and pharmaceutical composition
abstract COMPOUND, USE OF A COMPOUND AND PHARMACEUTICAL COMPOSITION. Compound of formula (I): X + Y = keto, or X = OH and Y = H, or X + Y = oxime or methyloxime group; B = OH and C + D = H, or C + D linear or branched C1 -C4 alkyl radicals, or C = H and D = linear or branched C1 -C4 alkyl radicals; or B + C = keto and D = methyl, hydroxyl or methyl amine; or B and C = H and D = methyl amino grouping; or B + C = oxime and D = methyl; and R = C1 -C10 straight or branched alkyl; salts, esters and salts of esters by way of medicament, notably applications as neuroprotectors, novel compounds of formula (I) and pharmaceutical compositions.
priorityDate 2004-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6329

Total number of triples: 34.